Establishment Labs (NASDAQ:ESTA) Trading Down 5.9% – What’s Next?

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) dropped 5.9% on Wednesday . The company traded as low as $44.05 and last traded at $43.49. Approximately 151,581 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 410,610 shares. The stock had previously closed at $46.20.

Analyst Ratings Changes

Separately, Stephens reiterated an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a report on Thursday, February 27th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $57.40.

Establishment Labs Stock Performance

The stock has a market cap of $1.24 billion, a P/E ratio of -17.19 and a beta of 1.12. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The company’s 50-day simple moving average is $37.55 and its 200 day simple moving average is $41.37.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The business had revenue of $44.51 million during the quarter, compared to analysts’ expectations of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. As a group, sell-side analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Institutional Investors Weigh In On Establishment Labs

Large investors have recently modified their holdings of the stock. Kornitzer Capital Management Inc. KS grew its holdings in Establishment Labs by 2.5% during the third quarter. Kornitzer Capital Management Inc. KS now owns 248,435 shares of the company’s stock valued at $10,750,000 after purchasing an additional 6,050 shares during the period. Black Swift Group LLC purchased a new position in shares of Establishment Labs during the 3rd quarter valued at $312,000. Simplify Asset Management Inc. grew its stake in shares of Establishment Labs by 67.7% during the 3rd quarter. Simplify Asset Management Inc. now owns 21,639 shares of the company’s stock worth $936,000 after acquiring an additional 8,732 shares during the period. Mudita Advisors LLP increased its holdings in Establishment Labs by 19.0% in the 3rd quarter. Mudita Advisors LLP now owns 354,801 shares of the company’s stock worth $15,352,000 after acquiring an additional 56,700 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in Establishment Labs by 1.8% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company’s stock valued at $1,525,000 after acquiring an additional 632 shares during the period. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.